SANGUINE CORPORATION SENIOR CONVERTIBLE PROMISSORY NOTE August 1, 2011Agreement • August 15th, 2011 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
This Agreement (the "Agreement") is made and entered into as of August 1, 2011 (the "Effective Date"), by and between Sanguine Corporation a Nevada corporation ("Borrower"), with a business address of 110 Founders Mill Ct., Roswell, GA 30075 and Wharton Capital LLC, a Delaware limited liability company ("Creditor"), with a business address of 15021 Ventura Blvd. Suite 504, Sherman Oaks, CA 91403. Borrower and Creditor will be referred to throughout the Agreement as "Parties" collectively and "Party" singularly.
